Milling TJ, et al. – This retrospective multicenter analysis aims to describe a cohort of patients with Factor Xa (FXa) inhibitor–associated life–threatening bleeding events, their clinical characteristics, interventions, and outcomes. The authors reveal that this cohort of FXa inhibitor–associated major bleeding scenarios deemed suitable for acute anticoagulant reversal shows the variable approaches in the absence of a specific reversal agent.